Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Succinyl-CoA:3-ketoacid coenzyme A transferase 2 (OXCT2) is a mitochondrial enzyme that catalyzes the transfer of a coenzyme A (CoA) group from succinyl-CoA to acetoacetate, a crucial step in the catabolism of ketone bodies. This enzyme plays an important role in energy metabolism by enabling tissues to utilize ketone bodies as an energy source, especially under metabolic conditions when glucose availability is limited. OXCT2 is most highly expressed in the testis, suggesting possible tissue specificity compared to the related OXCT1 isoform.
Enzymatic catalysis of CoA group transfer from succinate to acetoacetate, forming succinate and acetoacetyl-CoA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Succinyl-CoA:3-ketoacid coenzyme A transferase 2 (OXCT2).